A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis
Clinical trial NCT05201911 · COMPLETED
Trial details
- NCT number
- NCT05201911
- Sponsor
- Attralus, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2022-09-06
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.